The Chartis Group Selected as one of Modern Healthcare’s Best Places to Work in Healthcare for 2019

CHICAGO, May 13, 2019 /PRNewswire/ — The Chartis Group has been named to Modern Healthcare’s Best Places to Work in Healthcare for 2019. The complete list of this year’s winners, in alphabetical order is here.

In a statement Modern Healthcare noted, “Organizations making this year’s list of Best Places to Work in Healthcare stand out in their efforts to create an empowered and satisfied workforce. They did so by nurturing a sense of loyalty and building engagement.”

“We are honored to once again be named as one of Modern Healthcare’s Best Places to Work in Healthcare,” stated Shannon Brownell, Chief Talent Officer of The Chartis Group.
“Our mission to materially impact the delivery of healthcare has never been more critical or more meaningful for the highly talented colleagues who make Chartis such a unique place to work. Moreover, our growth has only amplified the warm, collegial culture that distinguishes us as a firm.”

Modern Healthcare will announce the ranked order at an awards gala on September 26, 2019 in Dallas following Modern Healthcare’s Workplace of the Future Conference.

About The Chartis Group

The Chartis Group® (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, children’s hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit www.chartis.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/the-chartis-group-selected-as-one-of-modern-healthcares-best-places-to-work-in-healthcare-for-2019-300849176.html

SOURCE The Chartis Group

Staff

Recent Posts

Evotec Closes Sale of Just – Evotec Biologics’ Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing…

35 minutes ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

4 hours ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

4 hours ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

19 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

19 hours ago